Gross Profit Summary of NGL Fine-Chem Limited

NGL Fine-Chem Limited's latest annual gross profit in 2023 was 1.23 Billion INR , down -10.54% from previous year.
NGL Fine-Chem Limited's latest quarterly gross profit in 2024 Q1 was 286.59 Million INR , down -23.45% from previous quarter.
NGL Fine-Chem Limited reported a annual gross profit of 1.37 Billion INR in annual gross profit 2022, down -16.93% from previous year.
NGL Fine-Chem Limited reported a annual gross profit of 1.65 Billion INR in annual gross profit 2021, up 8.63% from previous year.
NGL Fine-Chem Limited reported a quarterly gross profit of 439.74 Million INR for 2023 Q2, up 18.48% from previous quarter.
NGL Fine-Chem Limited reported a quarterly gross profit of 1.23 Billion INR for 2023 FY, down -10.54% from previous quarter.

Annual Gross Profit Chart of NGL Fine-Chem Limited (2023 - 2007)

Historical Annual Gross Profit of NGL Fine-Chem Limited (2023 - 2007)

Year	Gross Profit	Gross Profit Growth
2023	1.23 Billion INR	-10.54%
2022	1.37 Billion INR	-16.93%
2021	1.65 Billion INR	8.63%
2020	1.52 Billion INR	80.47%
2019	845.87 Million INR	-4.03%
2018	881.38 Million INR	35.45%
2017	650.69 Million INR	4.83%
2016	620.69 Million INR	11.89%
2015	554.75 Million INR	18.82%
2014	466.88 Million INR	21.23%
2013	385.11 Million INR	43.5%
2012	268.37 Million INR	54.27%
2011	173.96 Million INR	258.0%
2010	48.59 Million INR	4.78%
2009	46.37 Million INR	-64.57%
2008	130.9 Million INR	85.91%
2007	70.41 Million INR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	286.59 Million INR	-23.45%
2023 Q2	439.74 Million INR	18.48%
2023 FY	1.23 Billion INR	-10.54%
2023 Q4	374.4 Million INR	16.14%
2023 Q3	322.36 Million INR	-26.69%
2023 Q1	371.15 Million INR	-14.11%
2022 FY	1.37 Billion INR	-16.93%
2022 Q1	293.65 Million INR	-25.94%
2022 Q2	340.49 Million INR	15.95%
2022 Q3	351.42 Million INR	3.21%
2022 Q4	432.14 Million INR	22.97%
2021 Q1	436.06 Million INR	-3.65%
2021 Q4	396.52 Million INR	1.19%
2021 FY	1.65 Billion INR	8.63%
2021 Q3	391.87 Million INR	-9.37%
2021 Q2	432.38 Million INR	-0.84%
2020 Q1	254.66 Million INR	27.21%
2020 Q2	384.41 Million INR	50.95%
2020 FY	1.52 Billion INR	80.47%
2020 Q4	452.56 Million INR	4.02%
2020 Q3	435.06 Million INR	13.17%
2019 Q2	206.37 Million INR	-15.39%
2019 FY	845.87 Million INR	-4.03%
2019 Q3	195.38 Million INR	-5.32%
2019 Q1	243.92 Million INR	-1.78%
2019 Q4	200.19 Million INR	2.46%
2018 Q2	219.64 Million INR	9.06%
2018 Q1	201.39 Million INR	6.31%
2018 Q3	211.9 Million INR	-3.52%
2018 Q4	248.34 Million INR	17.19%
2018 FY	881.38 Million INR	35.45%
2017 Q3	172.67 Million INR	3.67%
2017 Q1	125.07 Million INR	-24.25%
2017 FY	650.69 Million INR	4.83%
2017 Q4	189.44 Million INR	9.71%
2017 Q2	166.56 Million INR	33.18%
2016 Q1	156.26 Million INR	2.16%
2016 Q2	137.19 Million INR	-12.2%
2016 FY	620.69 Million INR	11.89%
2016 Q4	165.12 Million INR	2.2%
2016 Q3	161.56 Million INR	17.76%
2015 FY	554.75 Million INR	18.82%
2015 Q4	152.95 Million INR	17.77%
2015 Q3	129.87 Million INR	-3.65%
2015 Q2	134.79 Million INR	-1.2%
2015 Q1	136.42 Million INR	-2.35%
2014 Q4	139.71 Million INR	44.69%
2014 Q3	96.56 Million INR	-19.75%
2014 Q2	120.31 Million INR	8.37%
2014 Q1	111.02 Million INR	24.61%
2014 FY	466.88 Million INR	21.23%
2013 Q1	103.03 Million INR	32.21%
2013 Q3	92.6 Million INR	-7.54%
2013 Q4	89.09 Million INR	-3.79%
2013 FY	385.11 Million INR	43.5%
2013 Q2	100.15 Million INR	-2.79%
2012 Q1	61.47 Million INR	35.38%
2012 Q3	70.22 Million INR	20.28%
2012 Q2	58.38 Million INR	-5.02%
2012 FY	268.37 Million INR	54.27%
2012 Q4	77.93 Million INR	10.97%
2011 FY	173.96 Million INR	258.0%
2011 Q4	45.4 Million INR	-1.52%
2011 Q3	46.1 Million INR	0.0%
2010 FY	48.59 Million INR	4.78%
2009 FY	46.37 Million INR	-64.57%
2008 FY	130.9 Million INR	85.91%
2008 Q4	41.47 Million INR	0.0%
2007 FY	70.41 Million INR	0.0%
2007 Q4	19.16 Million INR	0.0%

Peer Gross Profit Comparison of NGL Fine-Chem Limited

Name	Gross Profit	Gross Profit Difference
Abbott India Limited	26.16 Billion INR	95.29%
Cipla Limited	161.81 Billion INR	99.238%
Gland Pharma Limited	16.6 Billion INR	92.577%
GlaxoSmithKline Pharmaceuticals Limited	12.82 Billion INR	90.387%
Kopran Limited	2.12 Billion INR	42.045%
Marksans Pharma Limited	7.71 Billion INR	84.023%
Pfizer Limited	9.9 Billion INR	87.558%
Sanofi India Limited	16.32 Billion INR	92.451%
SMS Pharmaceuticals Limited	2.1 Billion INR	41.573%
TTK Healthcare Limited	2.68 Billion INR	54.124%

Global Stocks Search

NGL Fine-Chem Limited (NGLFINE.NS)

Gross Profit Summary of NGL Fine-Chem Limited

Annual Gross Profit Chart of NGL Fine-Chem Limited (2023 - 2007)

Historical Annual Gross Profit of NGL Fine-Chem Limited (2023 - 2007)

Peer Gross Profit Comparison of NGL Fine-Chem Limited